Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
Clinical trial NCT01956812 · TERMINATED
Trial details
- NCT number
- NCT01956812
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-11-01
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.